Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -41,225 | -33,629 | N/A | N/A |
| Depreciation Amortization | 2,390 | 1,913 | N/A | N/A |
| Accounts receivable | 1,118 | -4,352 | N/A | N/A |
| Accounts payable and accrued liabilities | -185 | 5,603 | N/A | N/A |
| Other Working Capital | 3,969 | -1,872 | N/A | N/A |
| Other Operating Activity | 2,203 | 657 | 0 | 0 |
| Operating Cash Flow | $-31,730 | $-31,680 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -450 | -1,355 | N/A | N/A |
| Purchase Of Investment | -21,119 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -318 | -1,678 | N/A | N/A |
| Other Investing Activity | -2,754 | -1,678 | 0 | 0 |
| Investing Cash Flow | $-24,323 | $-3,033 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 15,839 | N/A | N/A | N/A |
| Debt Repayment | -16,529 | -1,967 | N/A | N/A |
| Common Stock Issued | 108,715 | 1,760 | N/A | N/A |
| Other Financing Activity | -980 | -816 | 0 | 0 |
| Financing Cash Flow | $107,045 | $-1,023 | $N/A | $N/A |
| Exchange Rate Effect | 5,564 | -102 | N/A | N/A |
| Beginning Cash Position | 18,069 | 53,907 | N/A | N/A |
| End Cash Position | 74,625 | 18,069 | N/A | N/A |
| Net Cash Flow | $56,556 | $-35,838 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -31,730 | -31,680 | N/A | N/A |
| Capital Expenditure | -450 | -1,355 | N/A | N/A |
| Free Cash Flow | -32,180 | -33,035 | 0 | 0 |